Antimalarial activities of polyhydroxyphenyl and hydroxamic acid derivatives

Antimicrob Agents Chemother. 1998 Sep;42(9):2456-8. doi: 10.1128/AAC.42.9.2456.

Abstract

Several known mammalian ribonucleotide reductase inhibitors featuring a polyhydroxyphenyl and/or hydroxamate moiety as the active group were screened for potency in inhibiting growth of the malaria parasite Plasmodium falciparum. Compounds containing a 2,3- or 3,4-dihydroxyphenyl group as well as benzohydroxamate appear to be the most effective inhibitors of the malaria parasite.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Antimalarials / pharmacology*
  • Hydroxamic Acids / pharmacology*
  • Hydroxyurea / pharmacology
  • Plasmodium falciparum / drug effects
  • Ribonucleotide Reductases / antagonists & inhibitors*
  • Structure-Activity Relationship

Substances

  • Antimalarials
  • Hydroxamic Acids
  • Ribonucleotide Reductases
  • Hydroxyurea